nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—kidney cancer	0.289	0.463	CbGbCtD
L-Carnitine—CES1—Capecitabine—kidney cancer	0.171	0.274	CbGbCtD
L-Carnitine—SLC22A5—Dactinomycin—kidney cancer	0.0581	0.0931	CbGbCtD
L-Carnitine—SLCO1B1—Pazopanib—kidney cancer	0.0563	0.0902	CbGbCtD
L-Carnitine—XDH—Doxorubicin—kidney cancer	0.0498	0.0799	CbGbCtD
L-Carnitine—SLC22A16—renal system—kidney cancer	0.00501	0.0497	CbGeAlD
L-Carnitine—SLC22A16—kidney—kidney cancer	0.00485	0.048	CbGeAlD
L-Carnitine—SLC22A8—nephron—kidney cancer	0.00476	0.0471	CbGeAlD
L-Carnitine—SLC22A16—gonad—kidney cancer	0.0045	0.0445	CbGeAlD
L-Carnitine—CROT—nephron tubule—kidney cancer	0.00399	0.0395	CbGeAlD
L-Carnitine—SLC22A8—urine—kidney cancer	0.00381	0.0378	CbGeAlD
L-Carnitine—SLC25A20—nephron tubule—kidney cancer	0.00347	0.0344	CbGeAlD
L-Carnitine—CROT—cortex of kidney—kidney cancer	0.00341	0.0338	CbGeAlD
L-Carnitine—CRAT—nephron tubule—kidney cancer	0.00337	0.0333	CbGeAlD
L-Carnitine—SLC25A20—renal system—kidney cancer	0.00315	0.0312	CbGeAlD
L-Carnitine—CRAT—renal system—kidney cancer	0.00306	0.0303	CbGeAlD
L-Carnitine—SLC25A20—cortex of kidney—kidney cancer	0.00297	0.0294	CbGeAlD
L-Carnitine—CRAT—kidney—kidney cancer	0.00296	0.0293	CbGeAlD
L-Carnitine—CRAT—cortex of kidney—kidney cancer	0.00288	0.0285	CbGeAlD
L-Carnitine—SLC25A20—cardiac atrium—kidney cancer	0.00282	0.028	CbGeAlD
L-Carnitine—CRAT—gonad—kidney cancer	0.00274	0.0272	CbGeAlD
L-Carnitine—CRAT—cardiac atrium—kidney cancer	0.00274	0.0271	CbGeAlD
L-Carnitine—CPT2—nephron tubule—kidney cancer	0.00259	0.0256	CbGeAlD
L-Carnitine—CROT—Vinorelbine—Vinblastine—kidney cancer	0.00249	0.432	CbGdCrCtD
L-Carnitine—CROT—Vinorelbine—Vincristine—kidney cancer	0.00249	0.432	CbGdCrCtD
L-Carnitine—CPT1A—renal system—kidney cancer	0.00248	0.0246	CbGeAlD
L-Carnitine—CPT1A—kidney—kidney cancer	0.0024	0.0237	CbGeAlD
L-Carnitine—CPT2—renal system—kidney cancer	0.00235	0.0233	CbGeAlD
L-Carnitine—CPT2—kidney—kidney cancer	0.00228	0.0225	CbGeAlD
L-Carnitine—CPT1A—gonad—kidney cancer	0.00222	0.022	CbGeAlD
L-Carnitine—CPT2—cortex of kidney—kidney cancer	0.00222	0.0219	CbGeAlD
L-Carnitine—CPT2—gonad—kidney cancer	0.00211	0.0209	CbGeAlD
L-Carnitine—CPT2—cardiac atrium—kidney cancer	0.00211	0.0209	CbGeAlD
L-Carnitine—XDH—renal system—kidney cancer	0.00183	0.0182	CbGeAlD
L-Carnitine—Choline—ACHE—kidney cancer	0.00177	0.63	CrCbGaD
L-Carnitine—XDH—kidney—kidney cancer	0.00177	0.0175	CbGeAlD
L-Carnitine—SLCO1B1—renal system—kidney cancer	0.0012	0.0119	CbGeAlD
L-Carnitine—SLC22A4—nephron tubule—kidney cancer	0.00117	0.0116	CbGeAlD
L-Carnitine—MPO—renal system—kidney cancer	0.00117	0.0116	CbGeAlD
L-Carnitine—SLCO1B1—kidney—kidney cancer	0.00116	0.0115	CbGeAlD
L-Carnitine—MPO—kidney—kidney cancer	0.00113	0.0112	CbGeAlD
L-Carnitine—SLC22A4—renal system—kidney cancer	0.00107	0.0106	CbGeAlD
L-Carnitine—Choline—BCHE—kidney cancer	0.00104	0.37	CrCbGaD
L-Carnitine—SLC22A4—kidney—kidney cancer	0.00103	0.0102	CbGeAlD
L-Carnitine—SLC22A8—nephron tubule—kidney cancer	0.00103	0.0102	CbGeAlD
L-Carnitine—SLC22A4—cortex of kidney—kidney cancer	0.001	0.00994	CbGeAlD
L-Carnitine—SLC22A8—renal system—kidney cancer	0.000933	0.00924	CbGeAlD
L-Carnitine—SLC22A8—kidney—kidney cancer	0.000902	0.00893	CbGeAlD
L-Carnitine—SLC22A8—cortex of kidney—kidney cancer	0.000879	0.0087	CbGeAlD
L-Carnitine—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.000785	0.136	CbGdCrCtD
L-Carnitine—SLC22A5—nephron tubule—kidney cancer	0.000776	0.00768	CbGeAlD
L-Carnitine—SLC22A5—renal system—kidney cancer	0.000705	0.00698	CbGeAlD
L-Carnitine—SLC22A5—kidney—kidney cancer	0.000682	0.00675	CbGeAlD
L-Carnitine—SLC22A5—cortex of kidney—kidney cancer	0.000664	0.00658	CbGeAlD
L-Carnitine—SLC22A5—cardiac atrium—kidney cancer	0.000632	0.00626	CbGeAlD
L-Carnitine—Asthenia—Everolimus—kidney cancer	0.000243	0.00149	CcSEcCtD
L-Carnitine—Cough—Gemcitabine—kidney cancer	0.000242	0.00148	CcSEcCtD
L-Carnitine—Angiopathy—Paclitaxel—kidney cancer	0.000242	0.00148	CcSEcCtD
L-Carnitine—Pain—Sunitinib—kidney cancer	0.000242	0.00148	CcSEcCtD
L-Carnitine—Constipation—Sunitinib—kidney cancer	0.000242	0.00148	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Sorafenib—kidney cancer	0.00024	0.00147	CcSEcCtD
L-Carnitine—Renal failure—Capecitabine—kidney cancer	0.00024	0.00147	CcSEcCtD
L-Carnitine—Hypertension—Gemcitabine—kidney cancer	0.00024	0.00147	CcSEcCtD
L-Carnitine—Pruritus—Everolimus—kidney cancer	0.000239	0.00146	CcSEcCtD
L-Carnitine—Arrhythmia—Paclitaxel—kidney cancer	0.000239	0.00146	CcSEcCtD
L-Carnitine—Infection—Vincristine—kidney cancer	0.000237	0.00145	CcSEcCtD
L-Carnitine—Urinary tract infection—Capecitabine—kidney cancer	0.000237	0.00145	CcSEcCtD
L-Carnitine—Chest pain—Gemcitabine—kidney cancer	0.000236	0.00145	CcSEcCtD
L-Carnitine—Myalgia—Gemcitabine—kidney cancer	0.000236	0.00145	CcSEcCtD
L-Carnitine—Asthenia—Erlotinib—kidney cancer	0.000234	0.00143	CcSEcCtD
L-Carnitine—Decreased appetite—Dactinomycin—kidney cancer	0.000232	0.00142	CcSEcCtD
L-Carnitine—Diarrhoea—Vinblastine—kidney cancer	0.000232	0.00142	CcSEcCtD
L-Carnitine—Body temperature increased—Sorafenib—kidney cancer	0.000232	0.00142	CcSEcCtD
L-Carnitine—Abdominal pain—Sorafenib—kidney cancer	0.000232	0.00142	CcSEcCtD
L-Carnitine—Diarrhoea—Everolimus—kidney cancer	0.000231	0.00142	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000231	0.00141	CcSEcCtD
L-Carnitine—Pruritus—Erlotinib—kidney cancer	0.000231	0.00141	CcSEcCtD
L-Carnitine—Pain—Dactinomycin—kidney cancer	0.000229	0.0014	CcSEcCtD
L-Carnitine—Anorexia—Vincristine—kidney cancer	0.000228	0.00139	CcSEcCtD
L-Carnitine—Dysgeusia—Paclitaxel—kidney cancer	0.000228	0.00139	CcSEcCtD
L-Carnitine—Infection—Gemcitabine—kidney cancer	0.000225	0.00138	CcSEcCtD
L-Carnitine—Back pain—Paclitaxel—kidney cancer	0.000225	0.00138	CcSEcCtD
L-Carnitine—Dizziness—Vinblastine—kidney cancer	0.000225	0.00137	CcSEcCtD
L-Carnitine—Dizziness—Everolimus—kidney cancer	0.000224	0.00137	CcSEcCtD
L-Carnitine—Muscle spasms—Paclitaxel—kidney cancer	0.000224	0.00137	CcSEcCtD
L-Carnitine—Body temperature increased—Sunitinib—kidney cancer	0.000223	0.00137	CcSEcCtD
L-Carnitine—Abdominal pain—Sunitinib—kidney cancer	0.000223	0.00137	CcSEcCtD
L-Carnitine—Diarrhoea—Erlotinib—kidney cancer	0.000223	0.00137	CcSEcCtD
L-Carnitine—Hypotension—Vincristine—kidney cancer	0.000223	0.00137	CcSEcCtD
L-Carnitine—Haemoglobin—Capecitabine—kidney cancer	0.00022	0.00135	CcSEcCtD
L-Carnitine—Rhinitis—Capecitabine—kidney cancer	0.00022	0.00135	CcSEcCtD
L-Carnitine—Haemorrhage—Capecitabine—kidney cancer	0.000219	0.00134	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000219	0.00134	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000218	0.00133	CcSEcCtD
L-Carnitine—Pharyngitis—Capecitabine—kidney cancer	0.000218	0.00133	CcSEcCtD
L-Carnitine—Hypersensitivity—Sorafenib—kidney cancer	0.000216	0.00132	CcSEcCtD
L-Carnitine—Insomnia—Vincristine—kidney cancer	0.000216	0.00132	CcSEcCtD
L-Carnitine—Anorexia—Gemcitabine—kidney cancer	0.000216	0.00132	CcSEcCtD
L-Carnitine—Oedema peripheral—Capecitabine—kidney cancer	0.000216	0.00132	CcSEcCtD
L-Carnitine—Vomiting—Vinblastine—kidney cancer	0.000216	0.00132	CcSEcCtD
L-Carnitine—Dizziness—Erlotinib—kidney cancer	0.000216	0.00132	CcSEcCtD
L-Carnitine—Vomiting—Everolimus—kidney cancer	0.000215	0.00132	CcSEcCtD
L-Carnitine—Anaemia—Paclitaxel—kidney cancer	0.000215	0.00132	CcSEcCtD
L-Carnitine—Paraesthesia—Vincristine—kidney cancer	0.000215	0.00131	CcSEcCtD
L-Carnitine—Rash—Everolimus—kidney cancer	0.000213	0.00131	CcSEcCtD
L-Carnitine—Dermatitis—Everolimus—kidney cancer	0.000213	0.0013	CcSEcCtD
L-Carnitine—Headache—Vinblastine—kidney cancer	0.000213	0.0013	CcSEcCtD
L-Carnitine—Headache—Everolimus—kidney cancer	0.000212	0.0013	CcSEcCtD
L-Carnitine—Hypotension—Gemcitabine—kidney cancer	0.000212	0.0013	CcSEcCtD
L-Carnitine—Abdominal pain—Dactinomycin—kidney cancer	0.000211	0.00129	CcSEcCtD
L-Carnitine—Body temperature increased—Dactinomycin—kidney cancer	0.000211	0.00129	CcSEcCtD
L-Carnitine—Asthenia—Sorafenib—kidney cancer	0.000211	0.00129	CcSEcCtD
L-Carnitine—Vertigo—Paclitaxel—kidney cancer	0.000209	0.00128	CcSEcCtD
L-Carnitine—Hypersensitivity—Sunitinib—kidney cancer	0.000208	0.00127	CcSEcCtD
L-Carnitine—Decreased appetite—Vincristine—kidney cancer	0.000208	0.00127	CcSEcCtD
L-Carnitine—Pruritus—Sorafenib—kidney cancer	0.000208	0.00127	CcSEcCtD
L-Carnitine—Vomiting—Erlotinib—kidney cancer	0.000207	0.00127	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000207	0.00126	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000206	0.00126	CcSEcCtD
L-Carnitine—Rash—Erlotinib—kidney cancer	0.000206	0.00126	CcSEcCtD
L-Carnitine—Dermatitis—Erlotinib—kidney cancer	0.000206	0.00126	CcSEcCtD
L-Carnitine—Palpitations—Paclitaxel—kidney cancer	0.000205	0.00126	CcSEcCtD
L-Carnitine—Insomnia—Gemcitabine—kidney cancer	0.000205	0.00125	CcSEcCtD
L-Carnitine—Eye disorder—Capecitabine—kidney cancer	0.000205	0.00125	CcSEcCtD
L-Carnitine—Headache—Erlotinib—kidney cancer	0.000204	0.00125	CcSEcCtD
L-Carnitine—Constipation—Vincristine—kidney cancer	0.000204	0.00125	CcSEcCtD
L-Carnitine—Pain—Vincristine—kidney cancer	0.000204	0.00125	CcSEcCtD
L-Carnitine—Paraesthesia—Gemcitabine—kidney cancer	0.000204	0.00125	CcSEcCtD
L-Carnitine—Cough—Paclitaxel—kidney cancer	0.000203	0.00124	CcSEcCtD
L-Carnitine—Asthenia—Sunitinib—kidney cancer	0.000203	0.00124	CcSEcCtD
L-Carnitine—Dyspnoea—Gemcitabine—kidney cancer	0.000202	0.00124	CcSEcCtD
L-Carnitine—Nausea—Vinblastine—kidney cancer	0.000202	0.00123	CcSEcCtD
L-Carnitine—Convulsion—Paclitaxel—kidney cancer	0.000201	0.00123	CcSEcCtD
L-Carnitine—Nausea—Everolimus—kidney cancer	0.000201	0.00123	CcSEcCtD
L-Carnitine—Diarrhoea—Sorafenib—kidney cancer	0.000201	0.00123	CcSEcCtD
L-Carnitine—Hypertension—Paclitaxel—kidney cancer	0.000201	0.00123	CcSEcCtD
L-Carnitine—Pruritus—Sunitinib—kidney cancer	0.0002	0.00122	CcSEcCtD
L-Carnitine—Angiopathy—Capecitabine—kidney cancer	0.000199	0.00122	CcSEcCtD
L-Carnitine—Chest pain—Paclitaxel—kidney cancer	0.000198	0.00121	CcSEcCtD
L-Carnitine—Myalgia—Paclitaxel—kidney cancer	0.000198	0.00121	CcSEcCtD
L-Carnitine—Anxiety—Paclitaxel—kidney cancer	0.000197	0.00121	CcSEcCtD
L-Carnitine—Decreased appetite—Gemcitabine—kidney cancer	0.000197	0.00121	CcSEcCtD
L-Carnitine—Hypersensitivity—Dactinomycin—kidney cancer	0.000197	0.00121	CcSEcCtD
L-Carnitine—Arrhythmia—Capecitabine—kidney cancer	0.000196	0.0012	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000196	0.0012	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Vincristine—kidney cancer	0.000195	0.0012	CcSEcCtD
L-Carnitine—Dizziness—Sorafenib—kidney cancer	0.000194	0.00119	CcSEcCtD
L-Carnitine—Pain—Gemcitabine—kidney cancer	0.000194	0.00119	CcSEcCtD
L-Carnitine—Constipation—Gemcitabine—kidney cancer	0.000194	0.00119	CcSEcCtD
L-Carnitine—Nausea—Erlotinib—kidney cancer	0.000194	0.00119	CcSEcCtD
L-Carnitine—Diarrhoea—Sunitinib—kidney cancer	0.000193	0.00118	CcSEcCtD
L-Carnitine—Asthenia—Dactinomycin—kidney cancer	0.000192	0.00117	CcSEcCtD
L-Carnitine—Body temperature increased—Vincristine—kidney cancer	0.000189	0.00116	CcSEcCtD
L-Carnitine—Abdominal pain—Vincristine—kidney cancer	0.000189	0.00116	CcSEcCtD
L-Carnitine—Infection—Paclitaxel—kidney cancer	0.000189	0.00115	CcSEcCtD
L-Carnitine—Dysgeusia—Capecitabine—kidney cancer	0.000187	0.00114	CcSEcCtD
L-Carnitine—Dizziness—Sunitinib—kidney cancer	0.000187	0.00114	CcSEcCtD
L-Carnitine—Vomiting—Sorafenib—kidney cancer	0.000187	0.00114	CcSEcCtD
L-Carnitine—Tachycardia—Paclitaxel—kidney cancer	0.000185	0.00113	CcSEcCtD
L-Carnitine—Rash—Sorafenib—kidney cancer	0.000185	0.00113	CcSEcCtD
L-Carnitine—Dermatitis—Sorafenib—kidney cancer	0.000185	0.00113	CcSEcCtD
L-Carnitine—Back pain—Capecitabine—kidney cancer	0.000185	0.00113	CcSEcCtD
L-Carnitine—Headache—Sorafenib—kidney cancer	0.000184	0.00113	CcSEcCtD
L-Carnitine—Muscle spasms—Capecitabine—kidney cancer	0.000183	0.00112	CcSEcCtD
L-Carnitine—Diarrhoea—Dactinomycin—kidney cancer	0.000183	0.00112	CcSEcCtD
L-Carnitine—Anorexia—Paclitaxel—kidney cancer	0.000181	0.00111	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—kidney cancer	0.000181	0.00111	CcSEcCtD
L-Carnitine—Muscular weakness—Doxorubicin—kidney cancer	0.00018	0.0011	CcSEcCtD
L-Carnitine—Vomiting—Sunitinib—kidney cancer	0.00018	0.0011	CcSEcCtD
L-Carnitine—Body temperature increased—Gemcitabine—kidney cancer	0.000179	0.0011	CcSEcCtD
L-Carnitine—Rash—Sunitinib—kidney cancer	0.000178	0.00109	CcSEcCtD
L-Carnitine—Dermatitis—Sunitinib—kidney cancer	0.000178	0.00109	CcSEcCtD
L-Carnitine—Hypotension—Paclitaxel—kidney cancer	0.000177	0.00109	CcSEcCtD
L-Carnitine—Headache—Sunitinib—kidney cancer	0.000177	0.00108	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—kidney cancer	0.000177	0.00108	CcSEcCtD
L-Carnitine—Anaemia—Capecitabine—kidney cancer	0.000176	0.00108	CcSEcCtD
L-Carnitine—Hypersensitivity—Vincristine—kidney cancer	0.000176	0.00108	CcSEcCtD
L-Carnitine—Nausea—Sorafenib—kidney cancer	0.000174	0.00107	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000173	0.00106	CcSEcCtD
L-Carnitine—Insomnia—Paclitaxel—kidney cancer	0.000172	0.00105	CcSEcCtD
L-Carnitine—Vertigo—Capecitabine—kidney cancer	0.000171	0.00105	CcSEcCtD
L-Carnitine—Asthenia—Vincristine—kidney cancer	0.000171	0.00105	CcSEcCtD
L-Carnitine—Paraesthesia—Paclitaxel—kidney cancer	0.00017	0.00104	CcSEcCtD
L-Carnitine—Vomiting—Dactinomycin—kidney cancer	0.00017	0.00104	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—kidney cancer	0.00017	0.00104	CcSEcCtD
L-Carnitine—Dyspnoea—Paclitaxel—kidney cancer	0.000169	0.00104	CcSEcCtD
L-Carnitine—Palpitations—Capecitabine—kidney cancer	0.000169	0.00103	CcSEcCtD
L-Carnitine—Rash—Dactinomycin—kidney cancer	0.000169	0.00103	CcSEcCtD
L-Carnitine—Nausea—Sunitinib—kidney cancer	0.000168	0.00103	CcSEcCtD
L-Carnitine—Dyspepsia—Paclitaxel—kidney cancer	0.000167	0.00102	CcSEcCtD
L-Carnitine—Cough—Capecitabine—kidney cancer	0.000167	0.00102	CcSEcCtD
L-Carnitine—Decreased appetite—Paclitaxel—kidney cancer	0.000165	0.00101	CcSEcCtD
L-Carnitine—Hypertension—Capecitabine—kidney cancer	0.000165	0.00101	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000164	0.001	CcSEcCtD
L-Carnitine—Diarrhoea—Vincristine—kidney cancer	0.000163	0.001	CcSEcCtD
L-Carnitine—Asthenia—Gemcitabine—kidney cancer	0.000163	0.000995	CcSEcCtD
L-Carnitine—Myalgia—Capecitabine—kidney cancer	0.000162	0.000994	CcSEcCtD
L-Carnitine—Chest pain—Capecitabine—kidney cancer	0.000162	0.000994	CcSEcCtD
L-Carnitine—Constipation—Paclitaxel—kidney cancer	0.000162	0.000993	CcSEcCtD
L-Carnitine—Pain—Paclitaxel—kidney cancer	0.000162	0.000993	CcSEcCtD
L-Carnitine—Anxiety—Capecitabine—kidney cancer	0.000162	0.000991	CcSEcCtD
L-Carnitine—Weight increased—Doxorubicin—kidney cancer	0.000161	0.000983	CcSEcCtD
L-Carnitine—Pruritus—Gemcitabine—kidney cancer	0.00016	0.000982	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—kidney cancer	0.00016	0.000978	CcSEcCtD
L-Carnitine—Nausea—Dactinomycin—kidney cancer	0.000159	0.000972	CcSEcCtD
L-Carnitine—Dizziness—Vincristine—kidney cancer	0.000158	0.000967	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000155	0.00095	CcSEcCtD
L-Carnitine—Diarrhoea—Gemcitabine—kidney cancer	0.000155	0.000949	CcSEcCtD
L-Carnitine—Renal failure—Doxorubicin—kidney cancer	0.000155	0.000947	CcSEcCtD
L-Carnitine—Infection—Capecitabine—kidney cancer	0.000155	0.000947	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—kidney cancer	0.000153	0.000937	CcSEcCtD
L-Carnitine—Tachycardia—Capecitabine—kidney cancer	0.000152	0.00093	CcSEcCtD
L-Carnitine—Vomiting—Vincristine—kidney cancer	0.000152	0.00093	CcSEcCtD
L-Carnitine—Rash—Vincristine—kidney cancer	0.000151	0.000922	CcSEcCtD
L-Carnitine—Dermatitis—Vincristine—kidney cancer	0.000151	0.000921	CcSEcCtD
L-Carnitine—Abdominal pain—Paclitaxel—kidney cancer	0.00015	0.000918	CcSEcCtD
L-Carnitine—Body temperature increased—Paclitaxel—kidney cancer	0.00015	0.000918	CcSEcCtD
L-Carnitine—Headache—Vincristine—kidney cancer	0.00015	0.000916	CcSEcCtD
L-Carnitine—Anorexia—Capecitabine—kidney cancer	0.000148	0.000909	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—kidney cancer	0.000148	0.000904	CcSEcCtD
L-Carnitine—Hypotension—Capecitabine—kidney cancer	0.000146	0.000891	CcSEcCtD
L-Carnitine—Vomiting—Gemcitabine—kidney cancer	0.000144	0.000882	CcSEcCtD
L-Carnitine—Rash—Gemcitabine—kidney cancer	0.000143	0.000875	CcSEcCtD
L-Carnitine—Dermatitis—Gemcitabine—kidney cancer	0.000143	0.000874	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—kidney cancer	0.000142	0.000869	CcSEcCtD
L-Carnitine—Headache—Gemcitabine—kidney cancer	0.000142	0.000869	CcSEcCtD
L-Carnitine—Nausea—Vincristine—kidney cancer	0.000142	0.000869	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000142	0.000869	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—kidney cancer	0.000142	0.000867	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—kidney cancer	0.000141	0.000865	CcSEcCtD
L-Carnitine—Insomnia—Capecitabine—kidney cancer	0.000141	0.000862	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—kidney cancer	0.00014	0.000858	CcSEcCtD
L-Carnitine—Paraesthesia—Capecitabine—kidney cancer	0.00014	0.000856	CcSEcCtD
L-Carnitine—Hypersensitivity—Paclitaxel—kidney cancer	0.00014	0.000856	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—kidney cancer	0.000139	0.000852	CcSEcCtD
L-Carnitine—Dyspnoea—Capecitabine—kidney cancer	0.000139	0.00085	CcSEcCtD
L-Carnitine—Dyspepsia—Capecitabine—kidney cancer	0.000137	0.000839	CcSEcCtD
L-Carnitine—Asthenia—Paclitaxel—kidney cancer	0.000136	0.000833	CcSEcCtD
L-Carnitine—Decreased appetite—Capecitabine—kidney cancer	0.000135	0.000829	CcSEcCtD
L-Carnitine—Nausea—Gemcitabine—kidney cancer	0.000135	0.000824	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000134	0.000823	CcSEcCtD
L-Carnitine—Pruritus—Paclitaxel—kidney cancer	0.000134	0.000822	CcSEcCtD
L-Carnitine—Constipation—Capecitabine—kidney cancer	0.000133	0.000815	CcSEcCtD
L-Carnitine—Pain—Capecitabine—kidney cancer	0.000133	0.000815	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—kidney cancer	0.000132	0.000808	CcSEcCtD
L-Carnitine—Diarrhoea—Paclitaxel—kidney cancer	0.00013	0.000795	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—kidney cancer	0.000128	0.000785	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000127	0.00078	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—kidney cancer	0.000126	0.000773	CcSEcCtD
L-Carnitine—Dizziness—Paclitaxel—kidney cancer	0.000125	0.000768	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000125	0.00121	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PSMD7—kidney cancer	0.000124	0.0012	CbGpPWpGaD
L-Carnitine—Abdominal pain—Capecitabine—kidney cancer	0.000123	0.000754	CcSEcCtD
L-Carnitine—Body temperature increased—Capecitabine—kidney cancer	0.000123	0.000754	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000122	0.00118	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000122	0.00118	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000121	0.00117	CbGpPWpGaD
L-Carnitine—Vomiting—Paclitaxel—kidney cancer	0.000121	0.000739	CcSEcCtD
L-Carnitine—CPT2—Metabolism—SLC5A3—kidney cancer	0.000121	0.00117	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PGK1—kidney cancer	0.000121	0.00117	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000121	0.00117	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000121	0.00117	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000121	0.00117	CbGpPWpGaD
L-Carnitine—Dysgeusia—Doxorubicin—kidney cancer	0.00012	0.000737	CcSEcCtD
L-Carnitine—Rash—Paclitaxel—kidney cancer	0.00012	0.000732	CcSEcCtD
L-Carnitine—Dermatitis—Paclitaxel—kidney cancer	0.00012	0.000732	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—kidney cancer	0.000119	0.000728	CcSEcCtD
L-Carnitine—Headache—Paclitaxel—kidney cancer	0.000119	0.000728	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—kidney cancer	0.000118	0.000724	CcSEcCtD
L-Carnitine—CPT2—Metabolism—LDHB—kidney cancer	0.000118	0.00114	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—BCHE—kidney cancer	0.000117	0.00114	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SLC5A5—kidney cancer	0.000116	0.00112	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000116	0.00112	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000116	0.00112	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000115	0.00111	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Capecitabine—kidney cancer	0.000115	0.000702	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—ACHE—kidney cancer	0.000115	0.00111	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTT1—kidney cancer	0.000115	0.00111	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTT1—kidney cancer	0.000115	0.00111	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ACHE—kidney cancer	0.000115	0.00111	CbGpPWpGaD
L-Carnitine—Anaemia—Doxorubicin—kidney cancer	0.000114	0.000696	CcSEcCtD
L-Carnitine—Nausea—Paclitaxel—kidney cancer	0.000113	0.00069	CcSEcCtD
L-Carnitine—CROT—Metabolism—SLC2A1—kidney cancer	0.000112	0.00108	CbGpPWpGaD
L-Carnitine—Asthenia—Capecitabine—kidney cancer	0.000112	0.000684	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—kidney cancer	0.000111	0.000676	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—PPAT—kidney cancer	0.00011	0.00107	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GLIPR1—kidney cancer	0.00011	0.00107	CbGpPWpGaD
L-Carnitine—Pruritus—Capecitabine—kidney cancer	0.00011	0.000674	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000109	0.00105	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000109	0.00105	CbGpPWpGaD
L-Carnitine—Palpitations—Doxorubicin—kidney cancer	0.000109	0.000665	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—SCARB1—kidney cancer	0.000109	0.00105	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SCARB1—kidney cancer	0.000109	0.00105	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000108	0.00105	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000108	0.00104	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS1—kidney cancer	0.000107	0.00104	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS1—kidney cancer	0.000107	0.00104	CbGpPWpGaD
L-Carnitine—Cough—Doxorubicin—kidney cancer	0.000107	0.000657	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—kidney cancer	0.000107	0.000652	CcSEcCtD
L-Carnitine—Diarrhoea—Capecitabine—kidney cancer	0.000107	0.000652	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—kidney cancer	0.000106	0.00065	CcSEcCtD
L-Carnitine—CRAT—Metabolism—PSMD7—kidney cancer	0.000105	0.00102	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PSMD7—kidney cancer	0.000105	0.00102	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ACY1—kidney cancer	0.000105	0.00102	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000105	0.00101	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—kidney cancer	0.000105	0.00101	CbGpPWpGaD
L-Carnitine—Chest pain—Doxorubicin—kidney cancer	0.000105	0.000641	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—kidney cancer	0.000105	0.000641	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TP53—kidney cancer	0.000104	0.00101	CbGpPWpGaD
L-Carnitine—Anxiety—Doxorubicin—kidney cancer	0.000104	0.000639	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000104	0.00101	CbGpPWpGaD
L-Carnitine—Dizziness—Capecitabine—kidney cancer	0.000103	0.00063	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—FH—kidney cancer	0.000103	0.000992	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APRT—kidney cancer	0.000103	0.000992	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CA9—kidney cancer	0.000103	0.000992	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.0001	0.000969	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.0001	0.000969	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—BCHE—kidney cancer	9.99e-05	0.000966	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—BCHE—kidney cancer	9.99e-05	0.000966	CbGpPWpGaD
L-Carnitine—Infection—Doxorubicin—kidney cancer	9.97e-05	0.00061	CcSEcCtD
L-Carnitine—Vomiting—Capecitabine—kidney cancer	9.9e-05	0.000606	CcSEcCtD
L-Carnitine—CRAT—Metabolism—SLC5A5—kidney cancer	9.87e-05	0.000955	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SLC5A5—kidney cancer	9.87e-05	0.000955	CbGpPWpGaD
L-Carnitine—Rash—Capecitabine—kidney cancer	9.82e-05	0.000601	CcSEcCtD
L-Carnitine—Dermatitis—Capecitabine—kidney cancer	9.81e-05	0.000601	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—kidney cancer	9.8e-05	0.0006	CcSEcCtD
L-Carnitine—Headache—Capecitabine—kidney cancer	9.76e-05	0.000597	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—KRAS—kidney cancer	9.68e-05	0.000937	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GPC3—kidney cancer	9.64e-05	0.000932	CbGpPWpGaD
L-Carnitine—Anorexia—Doxorubicin—kidney cancer	9.57e-05	0.000586	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—SLC2A1—kidney cancer	9.53e-05	0.000922	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SLC2A1—kidney cancer	9.53e-05	0.000922	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.48e-05	0.000918	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	9.4e-05	0.00091	CbGpPWpGaD
L-Carnitine—Hypotension—Doxorubicin—kidney cancer	9.38e-05	0.000574	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—CA2—kidney cancer	9.38e-05	0.000907	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTP1—kidney cancer	9.35e-05	0.000904	CbGpPWpGaD
L-Carnitine—Nausea—Capecitabine—kidney cancer	9.25e-05	0.000566	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.25e-05	0.000895	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.25e-05	0.000895	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	9.16e-05	0.000886	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.15e-05	0.00056	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—ALAD—kidney cancer	9.14e-05	0.000884	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	9.08e-05	0.000879	CbGpPWpGaD
L-Carnitine—Insomnia—Doxorubicin—kidney cancer	9.08e-05	0.000556	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ANXA2—kidney cancer	9.06e-05	0.000876	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC5A3—kidney cancer	9.06e-05	0.000876	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP7B—kidney cancer	9.06e-05	0.000876	CbGpPWpGaD
L-Carnitine—Paraesthesia—Doxorubicin—kidney cancer	9.01e-05	0.000552	CcSEcCtD
L-Carnitine—XDH—Metabolism—PDHB—kidney cancer	8.96e-05	0.000867	CbGpPWpGaD
L-Carnitine—Dyspnoea—Doxorubicin—kidney cancer	8.95e-05	0.000548	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—ST3GAL2—kidney cancer	8.92e-05	0.000863	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ABCB1—kidney cancer	8.85e-05	0.000856	CbGpPWpGaD
L-Carnitine—Dyspepsia—Doxorubicin—kidney cancer	8.84e-05	0.000541	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—kidney cancer	8.73e-05	0.000534	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—ALDH1A1—kidney cancer	8.72e-05	0.000843	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CRABP1—kidney cancer	8.72e-05	0.000843	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.67e-05	0.000531	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.63e-05	0.000835	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTM1—kidney cancer	8.59e-05	0.000831	CbGpPWpGaD
L-Carnitine—Constipation—Doxorubicin—kidney cancer	8.58e-05	0.000525	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—kidney cancer	8.58e-05	0.000525	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—JUN—kidney cancer	8.56e-05	0.000828	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	8.5e-05	0.000823	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CCBL1—kidney cancer	8.42e-05	0.000815	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PGK1—kidney cancer	8.36e-05	0.000808	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC5A3—kidney cancer	8.36e-05	0.000808	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—PTEN—kidney cancer	8.28e-05	0.000801	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	8.21e-05	0.000794	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Doxorubicin—kidney cancer	8.21e-05	0.000502	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—LDHB—kidney cancer	8.2e-05	0.000793	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.19e-05	0.000793	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.19e-05	0.000793	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.19e-05	0.000793	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP1A1—kidney cancer	8.14e-05	0.000788	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ITPR2—kidney cancer	8.1e-05	0.000784	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.06e-05	0.00078	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.06e-05	0.00078	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTP1—kidney cancer	7.95e-05	0.000769	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTP1—kidney cancer	7.95e-05	0.000769	CbGpPWpGaD
L-Carnitine—Abdominal pain—Doxorubicin—kidney cancer	7.94e-05	0.000486	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—kidney cancer	7.94e-05	0.000486	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—ABCB1—kidney cancer	7.52e-05	0.000728	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ABCB1—kidney cancer	7.52e-05	0.000728	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.47e-05	0.000723	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—RAF1—kidney cancer	7.41e-05	0.000717	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Doxorubicin—kidney cancer	7.4e-05	0.000453	CcSEcCtD
L-Carnitine—CPT2—Metabolism—GSTT1—kidney cancer	7.39e-05	0.000715	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ACHE—kidney cancer	7.39e-05	0.000715	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GLIPR1—kidney cancer	7.3e-05	0.000707	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPAT—kidney cancer	7.3e-05	0.000707	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTM1—kidney cancer	7.3e-05	0.000707	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTM1—kidney cancer	7.3e-05	0.000707	CbGpPWpGaD
L-Carnitine—Asthenia—Doxorubicin—kidney cancer	7.2e-05	0.000441	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—CA9—kidney cancer	7.11e-05	0.000687	CbGpPWpGaD
L-Carnitine—Pruritus—Doxorubicin—kidney cancer	7.1e-05	0.000435	CcSEcCtD
L-Carnitine—CPT2—Metabolism—SCARB1—kidney cancer	7e-05	0.000677	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.95e-05	0.000672	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS1—kidney cancer	6.92e-05	0.00067	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP1A1—kidney cancer	6.92e-05	0.00067	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP1A1—kidney cancer	6.92e-05	0.00067	CbGpPWpGaD
L-Carnitine—Diarrhoea—Doxorubicin—kidney cancer	6.87e-05	0.00042	CcSEcCtD
L-Carnitine—CPT2—Metabolism—PSMD7—kidney cancer	6.79e-05	0.000657	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APRT—kidney cancer	6.79e-05	0.000657	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—FH—kidney cancer	6.79e-05	0.000657	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.69e-05	0.000647	CbGpPWpGaD
L-Carnitine—Dizziness—Doxorubicin—kidney cancer	6.64e-05	0.000406	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	6.46e-05	0.000625	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—BCHE—kidney cancer	6.44e-05	0.000623	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GPC3—kidney cancer	6.38e-05	0.000618	CbGpPWpGaD
L-Carnitine—Vomiting—Doxorubicin—kidney cancer	6.38e-05	0.000391	CcSEcCtD
L-Carnitine—CPT2—Metabolism—SLC5A5—kidney cancer	6.36e-05	0.000615	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.36e-05	0.000615	CbGpPWpGaD
L-Carnitine—Rash—Doxorubicin—kidney cancer	6.33e-05	0.000387	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—kidney cancer	6.32e-05	0.000387	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—kidney cancer	6.29e-05	0.000385	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	6.24e-05	0.000603	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.22e-05	0.000602	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.22e-05	0.000602	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.22e-05	0.000602	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CA2—kidney cancer	6.21e-05	0.000601	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SLC2A1—kidney cancer	6.14e-05	0.000594	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.14e-05	0.000594	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—POMC—kidney cancer	6.07e-05	0.000587	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALAD—kidney cancer	6.05e-05	0.000586	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CRABP1—kidney cancer	6.04e-05	0.000585	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—kidney cancer	5.96e-05	0.000365	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.96e-05	0.000576	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ST3GAL2—kidney cancer	5.91e-05	0.000572	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALDH1A1—kidney cancer	5.77e-05	0.000559	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.69e-05	0.00055	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.69e-05	0.00055	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—kidney cancer	5.65e-05	0.000547	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ITPR2—kidney cancer	5.62e-05	0.000543	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ACY1—kidney cancer	5.55e-05	0.000537	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PGK1—kidney cancer	5.54e-05	0.000536	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC5A3—kidney cancer	5.54e-05	0.000536	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—LDHB—kidney cancer	5.43e-05	0.000525	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.2e-05	0.000503	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.18e-05	0.000501	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—POMC—kidney cancer	5.16e-05	0.000499	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—POMC—kidney cancer	5.16e-05	0.000499	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ACHE—kidney cancer	5.12e-05	0.000496	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTT1—kidney cancer	5.12e-05	0.000496	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTP1—kidney cancer	5.12e-05	0.000496	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SCARB1—kidney cancer	4.85e-05	0.000469	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ABCB1—kidney cancer	4.85e-05	0.000469	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.85e-05	0.000469	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTGS2—kidney cancer	4.84e-05	0.000469	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS1—kidney cancer	4.8e-05	0.000464	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.78e-05	0.000462	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.73e-05	0.000458	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PDHB—kidney cancer	4.72e-05	0.000456	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PSMD7—kidney cancer	4.71e-05	0.000455	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTM1—kidney cancer	4.71e-05	0.000455	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CA9—kidney cancer	4.71e-05	0.000455	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.61e-05	0.000446	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP1A1—kidney cancer	4.46e-05	0.000432	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—BCHE—kidney cancer	4.46e-05	0.000432	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CCBL1—kidney cancer	4.43e-05	0.000429	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC5A5—kidney cancer	4.41e-05	0.000426	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.32e-05	0.000418	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC2A1—kidney cancer	4.26e-05	0.000412	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—kidney cancer	4.22e-05	0.000409	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.17e-05	0.000404	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.13e-05	0.0004	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—kidney cancer	4.12e-05	0.000398	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—kidney cancer	4.12e-05	0.000398	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.01e-05	0.000388	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CRABP1—kidney cancer	4e-05	0.000387	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GLIPR1—kidney cancer	3.84e-05	0.000372	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPAT—kidney cancer	3.84e-05	0.000372	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.8e-05	0.000367	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.76e-05	0.000364	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ITPR2—kidney cancer	3.72e-05	0.00036	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.67e-05	0.000355	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.64e-05	0.000352	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.6e-05	0.000348	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—kidney cancer	3.59e-05	0.000347	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—kidney cancer	3.59e-05	0.000347	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—FH—kidney cancer	3.57e-05	0.000346	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APRT—kidney cancer	3.57e-05	0.000346	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTP1—kidney cancer	3.55e-05	0.000343	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.49e-05	0.000338	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ACHE—kidney cancer	3.39e-05	0.000328	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTT1—kidney cancer	3.39e-05	0.000328	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ABCB1—kidney cancer	3.36e-05	0.000325	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPC3—kidney cancer	3.36e-05	0.000325	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—POMC—kidney cancer	3.33e-05	0.000322	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.29e-05	0.000319	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.28e-05	0.000317	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA2—kidney cancer	3.27e-05	0.000316	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—kidney cancer	3.26e-05	0.000316	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SCARB1—kidney cancer	3.21e-05	0.000311	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALAD—kidney cancer	3.19e-05	0.000308	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS1—kidney cancer	3.18e-05	0.000308	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.17e-05	0.000307	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PSMD7—kidney cancer	3.12e-05	0.000302	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ST3GAL2—kidney cancer	3.11e-05	0.000301	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1A1—kidney cancer	3.09e-05	0.000299	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDH1A1—kidney cancer	3.04e-05	0.000294	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—kidney cancer	2.98e-05	0.000288	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BCHE—kidney cancer	2.96e-05	0.000286	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC5A5—kidney cancer	2.92e-05	0.000282	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PGK1—kidney cancer	2.91e-05	0.000282	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC5A3—kidney cancer	2.91e-05	0.000282	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LDHB—kidney cancer	2.86e-05	0.000276	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A1—kidney cancer	2.82e-05	0.000273	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—RAF1—kidney cancer	2.74e-05	0.000265	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—kidney cancer	2.65e-05	0.000257	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.54e-05	0.000246	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—kidney cancer	2.53e-05	0.000245	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—kidney cancer	2.53e-05	0.000245	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.5e-05	0.000242	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA9—kidney cancer	2.48e-05	0.00024	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.42e-05	0.000234	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTP1—kidney cancer	2.35e-05	0.000228	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—kidney cancer	2.31e-05	0.000224	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—POMC—kidney cancer	2.31e-05	0.000223	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCB1—kidney cancer	2.23e-05	0.000215	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—kidney cancer	2.16e-05	0.000209	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CRABP1—kidney cancer	2.11e-05	0.000204	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—RAF1—kidney cancer	2.06e-05	0.000199	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1A1—kidney cancer	2.05e-05	0.000198	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ITPR2—kidney cancer	1.96e-05	0.000189	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	1.86e-05	0.00018	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—kidney cancer	1.84e-05	0.000178	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.81e-05	0.000175	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ACHE—kidney cancer	1.79e-05	0.000173	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTT1—kidney cancer	1.79e-05	0.000173	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SCARB1—kidney cancer	1.69e-05	0.000164	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS1—kidney cancer	1.67e-05	0.000162	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PSMD7—kidney cancer	1.64e-05	0.000159	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—kidney cancer	1.63e-05	0.000158	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—kidney cancer	1.6e-05	0.000155	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BCHE—kidney cancer	1.56e-05	0.000151	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.54e-05	0.000149	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—POMC—kidney cancer	1.53e-05	0.000148	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.48e-05	0.000144	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.44e-05	0.000139	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.42e-05	0.000137	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.26e-05	0.000121	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.24e-05	0.00012	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—kidney cancer	1.22e-05	0.000118	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.17e-05	0.000113	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—kidney cancer	1.14e-05	0.00011	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—kidney cancer	1.13e-05	0.000109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1A1—kidney cancer	1.08e-05	0.000104	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—kidney cancer	1.06e-05	0.000103	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.86e-06	8.57e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—POMC—kidney cancer	8.04e-06	7.78e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—kidney cancer	7.5e-06	7.25e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—kidney cancer	6.41e-06	6.2e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—kidney cancer	5.59e-06	5.41e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.95e-06	3.82e-05	CbGpPWpGaD
